Around the Rheum Canadian Rheumatology Association

A new class of medications, Immune Checkpoint Inhibitors, have revolutionized the treatment of various forms of cancer by harnessing the immune system fight to these diseases.  Unfortunately, these powerful drugs are sometimes associated with the development of autoimmune toxicities, otherwise known as immune-related adverse events (irAE). Enter rheumatology!
Join Daniel Ennis as he talks with two of the founding members of the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO), Dr. Carrie Ye and Dr. Shahin Jamal, about this expanding area of rheumatology practice and research.
Dr. Carrie Ye is a rheumatologist and clinical assistant professor at the University of Alberta.
Dr. Shahin Jamal is a rheumatologist and clinical associate professor at the University of British Columbia.

In this episode, we talk to two Rheumatologists in Montreal, the epicenter of the pandemic in Canada.  Listen in on a discussion about their experiences as they set aside their practices to help on the COVID-19 wards of the Jewish General Hospital.
Join our host, Dr. Daniel Ennis, as we unpack this subject within the context of the current pandemic.
Note: This episode was originally recorded on 6/9/2020, prior to more extensive research on plaquenil being available.

About our guests:
Dr. Marie Hudson is a Rheumatologist and epidemiologist at the Jewish General Hospital in Montreal and a senior scientist at the Lady Davis Institute for Medical Research.
Dr. Sabrina Fallavolita is also a rheumatologist at the Jewish General and the Site director for the Rheumatology program.
Dr. Daniel Ennis is a Rheumatologist and Vasculitis Specialist at the University of British Columbia in Vancouver, BC.

Over the next few months, the CRA’s Around the Rheum podcast will be exploring Canadian perspectives of COVID-19 and how it has affected different groups.
Description:
On May 6, 2020, The Lancet published (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31094-1/fulltext) a case series of 8 paediatric patients with a hyperinflammatory shock syndrome. Since then, similar cases have been documented throughout Europe, the United States, and now in Canada.
In this episode, Dr. Marie-Paule Morin guides us through the evolving literature around a new clinical entity: Paediatric inflammatory multi-system syndrome (PIMS). Dr. Morin works in Montreal, QC, a Canadian hotspot for COVID-19, and has first-hand experience working with children suspected of having PIMS.  Join our host, Dr. Daniel Ennis, as we unpack this subject within the context of the current pandemic.
Bios:

* Dr. Marie-Paule Morin is a Paediatric Rheumatologist at St Justine University Hospital in Montreal.
* Dr. Daniel Ennis is a Rheumatologist and Vasculitis Specialist at the University of British Columbia in Vancouver, BC.

In this episode, our host Dr. Daniel Ennis is joined by Dr. Michelle Teo and Dr. Janet Pope in a discussion about the merits as well as the pitfalls of the two main streams in rheumatology, community or academic.Our guests offer their expert perspectives on a career choice that many young rheumatologists and trainees can find extremely challenging.
Dr. Teo is a rheumatologist and clinical Instructor with the University of British Columbia.  She is in private practice in Penticton, BC. Dr. Pope is a Professor of Medicine at Western University and is the Division Head of Rheumatology at St. Joseph's Health Centre, London.Dr. Ennis is a Rheumatologist and Vasculitis Specialist at the University of British Columbia.

Welcome to Around the Rheum! In our inaugural episode, we interview Dr. Mary-Ann Fitzcharles, the lead author of the Canadian Rheumatology Association’s position statement on Medical Cannabis (published in 2019).

Join our host, Dr. Daniel Ennis, as we unpack this position statement and dive into the future of Medical Cannabis from a uniquely Canadian perspective.
 

Welcome to Around the Rheum, a brand new podcast from the Canadian Rheumatology Association, where we discuss the biggest issues facing Canadian rheumatologists and talk to the leading experts in the field. Welcome to the conversation!